Our Company
About Us
About Xanamem
®
Our Team
Recent Annual Reports
Our Strategic Priorities
Corporate Governance
Xanamem
®
The Cortisol Hypothesis
Mechanism of Action
Publications
Clinical Trials
Clinical Development Pipeline
Cognitive Impairment in early Alzheimer’s Disease
Cognitive Impairment in MDD
Anxiety, sleep & behavioral problems in Fragile X Syndrome
Patient Portal
Participate in clinical trials
The XanaCIDD Depression Clinical Trial
The XanaMIA Phase 2b Alzheimer’s Trial
Publications
Investor Centre
Share Price
ASX Announcements
Corporate Presentations
Analyst Reports
Financial Results Centre
Annual General Meeting
General Meeting
Financial Calendar
Right to Receive Documents
Frequently Asked Questions
Investor Contacts
News
Contact Us
Share Price
Summary
Share Price
Financial Results Centre
ASX Announcements
Corporate Presentations
Analyst Reports
Financial Calendar
Latest results
2023 Full Year Results
View Results Centre
2023 Annual General Meeting
Actinogen’s next Annual General Meeting
Date: November 2023 (TBA)
Read more
Back
to top